SAINT LAURENT, QUEBEC -- (MARKET WIRE) -- April 30, 2007 -- IntelGenx Technologies Corporation (OTCBB: IGXT)("IntelGenx" or the "Company") today announced that the company signed a licensing and development agreement with a major US pharmaceutical company for the development and commercialization of a generic product.
